https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force Report-Part VI https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9640 Sat 24 Mar 2018 08:35:24 AEDT ]]> Health technology assessment, international reference pricing, and budget control tools from China's perspective: what are the current developments and future considerations? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29975 Sat 24 Mar 2018 07:37:39 AEDT ]]>